Valentina N. Perfilova

Prof. Valentina N. Perfilova


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2021 in Biochemistry (Moscow)
Verified
Journal Article
Closed access
PDF file
ITIvan N. Tyurenkov
Ivan N. Tyurenkov
VPValentina N. Perfilova
Valentina N. Perfilova
ANAlla A. Nesterova
Alla A. Nesterova
YGYelena Glinka
Yelena Glinka
Klotho protein affects a number of metabolic pathways essential for pathogenesis of cardio-vascular diseases and their prevention. It inhibits lipid peroxidation and inflammation, as well as prevents endothelial injury and calcification of blood vessels. Klotho decreases rigidity of blood vessels and suppresses development of the heart fibrosis. Low level of its expression is associated with a number of diseases. Cardioprotective effect of klotho is based on its ability to interact with multiple receptors and ion channels. Being a pleiotropic protein, klotho could be a useful target for therapeutic intervention in the treatment of cardio-vascular diseases. In this review we present data on pharmaceuticals that stimulate klotho expression and suggest some promising research directions.

1 February 2019 in Phytomedicine
Verified
Journal Article
Closed access
GLG.M. Latypova
G.M. Latypova
MBM.A. Bychenkova
M.A. Bychenkova
VKV.A. Katayev
V.A. Katayev
VPValentina N. Perfilova
Valentina N. Perfilova
ITI.N. Tyurenkov
I.N. Tyurenkov
GIG.R. Iksanova
G.R. Iksanova

1 May 2014 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
ITI. N. Tyurenkov
I. N. Tyurenkov
VPValentina N. Perfilova
Valentina N. Perfilova
LRL. B. Reznikova
L. B. Reznikova
LSL. A. Smirnova
L. A. Smirnova
ARA. F. Ryabukha
A. F. Ryabukha
KKK. A. Kuznetsov
K. A. Kuznetsov

1 June 2021 in Alcohol
Verified
Journal Article
Closed access
VPValentina N. Perfilova
Valentina N. Perfilova
MKMargarita V. Kustova
Margarita V. Kustova
TPTamara A. Popova
Tamara A. Popova
GKGulnara H. Khusainova
Gulnara H. Khusainova
IPIgor I. Prokofiev
Igor I. Prokofiev
ITIvan N. Tyurenkov
Ivan N. Tyurenkov

4 March 2023 in Annals of the Russian academy of medical sciences
Verified
Journal Article
Open access
PDF file
KNKristina I. Nesterova
Kristina I. Nesterova
YGYelena Yu. Glinka
Yelena Yu. Glinka
VPValentina N. Perfilova
Valentina N. Perfilova
ANAlla A. Nesterova
Alla A. Nesterova
KKKamil D. Kaplanov
Kamil D. Kaplanov
ГЮГлинка Елена Юрьевна
Глинка Елена Юрьевна
-Isomer of Klotho Protein has been actively studied over the past 20 years. It has been found that -Klotho is closely associated with aging and has anti-aging properties. Besides, it is involved in development of malignant tumor diseases. Its universal influence on many biological mechanisms leading to hyperplastic changes in cells and tissues has been proven experimentally. Recent studies demonstrated inhibitory effect of -Klotho on the classical carcinogenic pathways such as insulin-like growth factor 1 (IGF1), fibroblast growth factor (FGFs), transforming growth factor 1 (TGFb1), Wnt, P53/p21, oxidative stress response pathways. Impeding effect of -Klotho protein on the development of such types of malignant tumors as breast, pancreatic, lung, stomach, hepatocarcinoma, and others is proven in a number of cases. This review describes the role of -Klotho in oncogenesis, its involvement and influence on the main signaling pathways known for their role in the development of malignant tumors, and the possibility of regulating its expression.

1 August 2018 in Biomeditsinskaya Khimiya
Verified
Journal Article
Closed access
TPT.A. Popova
T.A. Popova
EME.A. Muzyko
E.A. Muzyko
MKM.V. Kustova
M.V. Kustova
MBM.A. Bychenkova
M.A. Bychenkova
VPValentina N. Perfilova
Valentina N. Perfilova
VKV.A. Kataev
V.A. Kataev
Experimental chronic heart failure (CHF), caused by administration of L-isoproterenol (2.5 mg/kg twice a day intraperitoneally for 21 days), promotes uncoupling of respiration and oxidative phosphorylation. The rate of mitochondrial oxygen consumption in the metabolic state V3 by Chance in animals with CHF decreased by 53.3% (p<0.05) with malate using (as an oxidation substrate feeding сomplex I of the electron transport chain (ETC)), by 70.6% (p<0.05) with succinate using (сomplex II substrate) and by 63.6% (p<0.05) when malate and succinate were added simultaneously. The respiratory control ratio significantly decreased 2.3 times for сomplex I, 2.5 for сomplex II, and 2.6 times for the simultaneous operation of two respiratory chain complexes in mitochondria of CHF rats compared to intact animals. Mitochondrial dysfunction in experimental CHF is evidently due to the development of oxidative stress. It was revealed that the content of malonic dialdehyde (MDA) in the group of rats with experimental CHF was higher by 54.7% (p<0.05), as compared with intact animals. The activity of superoxide dismutase (SOD) and catalase was lower by 17.5% (p<0.05), and by 18.4%, respectively than in the intact group. The dense extract from herba of Primula veris L. (DEHPV) 30 mg/kg limits the development of mitochondrial dysfunction in rats with experimental CHF, as evidenced by an increase in the role of V3 respiration for the first and second respiratory chain complexes in 1.7 (p<0.05) and 2.0 times (p<0.05), respectively, the ratio of respiratory control (RCR) – 1.7 times (p<0.05) for сomplex I and 2 times (p<0.05) for сomplex II compared with the negative control. The concentration of MDA was by 15.7% (p<0.05), lower and the activity of SOD was by 56.3% (p<0.05) higher.